No Data
Top Executives Unload Major Shares in PROCEPT BioRobotics!
Procept Biorobotics Insider Sold Shares Worth $975,810, According to a Recent SEC Filing
Jefferies Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating, Maintains Target Price $77
Stocks That Could Be Safe From Tariffs Risk Compared to Their Industry Peers
Morgan Stanley Fund: Humanoid robots will gradually enter the mass production phase by 2025.
Currently, the humanoid robot industry both domestically and internationally is mainly divided into three major forces: automotive companies, robot companies, and Internet companies. The primary demand for humanoid robots such as those from Tesla is the ability for scaled production and cost reduction.
Procept Biorobotics Earnings Call Highlights Growth and Challenges
Tesla 1st : Agreed